Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 8/2018

01-08-2018 | Pictorial essay

Uncommon evolutions and complications of common benign liver lesions

Authors: Federica Vernuccio, Maxime Ronot, Marco Dioguardi Burgio, Jérôme Lebigot, Wassim Allaham, Christophe Aubé, Giuseppe Brancatelli, Valérie Vilgrain

Published in: Abdominal Radiology | Issue 8/2018

Login to get access

Abstract

Frequently encountered on abdominal imaging studies, the majority of common benign liver lesions are asymptomatic, confidently diagnosed by imaging, and do not require further workup, follow-up, or treatment. The increasing use of multimodality liver imaging, has allowed the recognition of uncommon evolutions of common benign liver lesions such as size changes, fibrotic regression, and content and vascularization changes, and their complications such as rupture, hemorrhage, thrombosis, extrinsic compression, and malignancy. The purpose of this pictorial review is to describe and illustrate the incidence and diagnostic features of these uncommon evolutions and complications on cross-sectional imaging, mainly on computed tomography and magnetic resonance imaging, with emphasis on those imaging clues which are helpful in the differential diagnosis or indicate the need for treatment.
Literature
1.
Kaltenbach TE, Engler P, Kratzer W, et al. (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol 41:25–32PubMedCentralCrossRef
2.
Rungsinaporn K, Phaisakamas T (2008) Frequency of abnormalities detected by upper abdominal ultrasound. J Med Assoc Thai 91:1072–1075PubMed
3.
4.
Tonolini M, Rigiroli F, Bianco R (2014) Symptomatic and complicated nonhereditary developmental liver cysts: cross-sectional imaging findings. Emerg Radiol 21:301–308PubMedCrossRef
5.
Vuillemin-Bodaghi V, Zins M, Vullierme MP, et al. (1997) Imaging of atypical cysts of the liver. Study of 26 surgically treated cases. Gastroenterol Clin Biol 21:394–399PubMed
6.
Schiff ER (2009) Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease. Gastroenterol Hepatol (NY) 5:414–416
7.
Valla D (1995) Kystes simples du foie. Méd Thér 1:237–241
8.
Bistritz L, Tamboli C, Bigam D, Bain VG (2005) Polycystic liver disease: experience at a teaching hospital. Am J Gastroenterol 100:2212–2217PubMedCrossRef
9.
Garcea G, Pattenden CJ, Stephenson J, Dennison AR, Berry DP (2007) Nine-year single-center experience with nonparastic liver cysts: diagnosis and management. Dig Dis Sci 52:185–191PubMedCrossRef
10.
Le Borgne J, Guilberteau-Canfrère V, Bruley des Varannes S, Sagan C (1995) Les kystes biliaires simples. Hepato-gastro 2:129–137
11.
Fong ZV, Wolf AM, Doria C, et al. (2012) Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management. J Gastrointest Surg 16:1782–1789PubMedCrossRef
12.
Kim JW, Lee CK, Shim JJ, Jang JY (2013) Cysto-duodenal fistula: an unusual complication of a nonparasitic hepatic cyst. Endoscopy 45(Suppl 2):E382–E383 (UCTN)PubMed
13.
Marion Y, Brevartt C, Plard L, Chiche L (2013) Hemorrhagic liver cyst rupture: an unusual life-threatening complication of hepatic cyst and literature review. Ann Hepatol 12:336–339PubMed
14.
Takahashi G, Yoshida H, Mamada Y, et al. (2008) Intracystic hemorrhage of a large simple hepatic cyst. J Nippon Med Sch 75:302–305PubMedCrossRef
15.
Naganuma H, Funaoka M, Fujimori S, et al. (2006) Hepatic cyst with intracystic bleeding: contrast-enhanced sonographic findings. J Med Ultrason 33:105–107CrossRef
16.
Akiyama T, Inamori M, Saito S, et al. (2008) Levovist ultrasonography imaging in intracystic hemorrhage of simple liver cyst. World J Gastroenterol 14:805–807PubMedPubMedCentralCrossRef
17.
18.
Desouza RM, Prachalias A, Srinivasan P, O’Doherty M, Olsburgh J (2009) Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplant Proc 41:1942–1945PubMedCrossRef
19.
Yamada T, Furukawa K, Yokoi K, et al. (2009) Liver cyst with biliary communication successfully treated with laparoscopic deroofing: a case report. J Nippon Med Sch 76:103–108PubMedCrossRef
20.
European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef
21.
Vilgrain V, Boulos L, Vullierme MP, et al. (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20:379–397PubMedCrossRef
22.
Jang HJ, Kim TK, Lim HK, et al. (2003) Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR 180:135–141PubMedCrossRef
23.
Yeh WC, Yang PM, Huang GT, Sheu JC, Chen DS (2007) Long-term follow-up of hepatic hemangiomas by ultrasonography: with emphasis on the growth rate of the tumor. Hepatogastroenterology 54:475–479PubMed
24.
Hasan HY, Hinshaw JL, Borman EJ, et al. (2014) Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg 149:1266–1271PubMedCrossRef
25.
Jing L, Liang H, Caifeng L, et al. (2016) New recognition of the natural history and growth pattern of hepatic hemangioma in adults. Hepatol Res 46:727–733PubMedCrossRef
26.
27.
Kim GE, Thung SN, Tsui WM, Ferrell LD (2006) Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int 26:334–338PubMedCrossRef
28.
Guillonnet A, Sibileau E, Benadjaoud S, et al. (2013) Spontaneous and simultaneous regression of multiple hepatic haemangiomas: first case reported. Diagn Interv Imaging 94:897–900PubMedCrossRef
29.
Duran R, Ronot M, Di Renzo S, et al. (2015) Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver? Eur J Radiol 84:816–822PubMedCrossRef
30.
Brancatelli G, Federle MP, Blachar A, Grazioli L (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219:69–74PubMedCrossRef
31.
Mahajan D, Miller C, Hirose K, McCullough A, Yerian L (2008) Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol 49:867–870PubMedCrossRef
32.
Yamashita S, Okita K, Harada K, et al. (2013) Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol 6:55–62PubMedCrossRef
33.
Hashimoto M, Sugawara M, Ishiyama K, et al. (2008) Reduction in the size of a hepatic haemangioma after chemotherapy. Liver Int 28:1043–1044PubMedCrossRef
34.
Lee M, Choi JY, Lim JS, et al. (2016) Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas. Angiogenesis 19:147–153PubMedCrossRef
35.
Kim KW, Kim AY, et al. (2006) Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR 187:W406–W414PubMedCrossRef
36.
Kim KW, Kim TK, Han JK, et al. (2001) Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology 219:707–711PubMedCrossRef
37.
Blachar A, Federle MP, Brancatelli G (2002) Hepatic capsular retraction: spectrum of benign and malignant etiologies. Abdom Imaging 27:690–699PubMedCrossRef
38.
Mitsudo K, Watanabe Y, Saga T, et al. (1995) Nonenhanced hepatic cavernous hemangioma with multiple calcifications: CT and pathologic correlation. Abdom Imaging 20:459–461PubMedCrossRef
39.
40.
Choi BI, Han MC, Park JH, et al. (1989) Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases. AJR 152:1221–1226PubMedCrossRef
41.
Ros PR, Lubbers PR, Olmsted WW, Morillo G (1987) Hemangioma of the liver: heterogeneous appearance on T2-weighted images. AJR 149:1167–1170PubMedCrossRef
42.
Mocchegiani F, Vincenzi P, Coletta M, et al. (2016) Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. Dig Liver Dis 48:309–314PubMedCrossRef
43.
Bornman PC, Terblanche J, Blumgart RL, et al. (1987) Giant hepatic hemangiomas: diagnostic and therapeutic dilemmas. Surgery 101:445–449PubMed
44.
Poupardin E, Régimbeau JM, Kianmanesh R, et al. (2002) Giant hemangioma of the liver revealed by an inflammatory syndrome. Gastroenterol Clin Biol 26:93–95PubMed
45.
van Gorcum M, van Buuren HR, Hussain SM, et al. (2005) Fever as a sign of inflammatory syndrome in a female patient with hepatic haemangioma. Ned Tijdschr Geneeskd 149:1227–1230PubMed
46.
Pateron D, Babany G, Belghiti J, et al. (1991) Giant hemangioma of the liver with pain, fever, and abnormal liver tests. Report of two cases. Dig Dis Sci 36:524–527PubMedCrossRef
47.
Kasabach HH, Merritt KK (1940) Capillary hemangioma with extensive purpura. Am J Dis 59:1063–1070CrossRef
48.
Hochwald SN, Blumgart LH (2000) Giant hepatic hemangioma with Kasabach-Merritt syndrome: is the appropriate treatment enucleation or liver transplantation? HPB Surg 11:413–419PubMedPubMedCentralCrossRef
49.
Yoon SS, Charny CK, Fong Y, et al. (2003) Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 197:392–402PubMedCrossRef
50.
Ha CD, Kubomoto SM, Whetstone BM, Parascandola S (2013) Pedunculated hepatic hemangiomas often misdiagnosed despite their typical findings. Open Surg J 7:1–5CrossRef
51.
Moon HK, Kim HS, Heo GM, et al. (2011) A case of pedunculated hepatic hemangioma mimicking submucosal tumor of the stomach. Korean J Hepatol 17:66–67PubMedPubMedCentralCrossRef
52.
Ersoz F, Ozcan O, Toros AB, et al. (2010) Torsion of a giant pedunculated liver hemangioma mimicking acute appendicitis: a case report. World J Emerg Surg 5:2PubMedPubMedCentralCrossRef
53.
Liang RJ, Chen CH, Chang YC, et al. (2002) Pedunculated hepatic hemangioma: report of two cases. J Formos Med Assoc 101:437–441PubMed
54.
Blondet A, Ridereau-Zins C, Michalak S, et al. (2007) Multiple pedunculated liver hemangiomas presenting with volvulus. J Radiol 88:891–894PubMedCrossRef
55.
Madhusudhan KS, Srivastava DN, Gamanagatti S (2009) Giant hemangioma of liver presenting as deep vein thrombosis of the lower limbs. J Postgrad Med 55:290–291PubMedCrossRef
56.
Akbulut S, Yilmaz M, Kahraman A, Yilmaz S (2013) Bilateral lower limb edema caused by compression of the retrohepatic inferior vena cava by a giant hepatic hemangioma. Int Surg 98:229–233PubMedPubMedCentralCrossRef
57.
58.
Yano T, Kobayashi T, Kuroda S, et al. (2015) Obstructive jaundice caused by a giant liver hemangioma with Kasabach-Merritt syndrome: a case report. Surg Case Rep 1:93PubMedPubMedCentralCrossRef
59.
60.
Pillon M, Carucci NS, Mainardi C, et al. (2015) Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 50:414–419PubMedCrossRef
61.
Grazioli L, Morana G, Federle MP, et al. (2001) Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 221:731–739PubMedCrossRef
62.
Kuo YH, Wang JH, Lu SN, et al. (2009) Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound 37:132–137PubMedCrossRef
63.
Bioulac-Sage P, Balabaud C, Wanless IR (2001) Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 25:1322–1325PubMedCrossRef
64.
Hohler T, Lohse AW, Schirmacher P (2000) Progressive focal nodular hyperplasia of the liver in a patient with genetic hemochromatosis: growth promotion by iron overload? Dig Dis Sci 45:587–590PubMedCrossRef
65.
Kaji K, Kaneko S, Matsushita E, et al. (1998) A case of progressive multiple focal nodular hyperplasia with alteration of imaging studies. Am J Gastroenterol 93:2568–2572PubMedCrossRef
66.
Sadowski DC, Lee SS, Wanless IR, Kelly JK, Heathcote EJ (1995) Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 21:970–975PubMedCrossRef
67.
Sato A, Rai T, Takahashi A, et al. (2006) A case of rapidly expanding and increasing focal nodular hyperplasia. Fukushima J Med Sci 52:149–155PubMedCrossRef
68.
Kayhan A, Venu N, Lakadamyalı H, Jensen D, Oto A (2010) Multiple progressive focal nodular hyperplasia lesions of liver in a patient with hemosiderosis. World J Radiol 2:405–409PubMedPubMedCentralCrossRef
69.
Kudo M, Zheng RQ, Chung H, et al. (2008) Long-term follow-up of atypical progressive focal nodular hyperplasia increasing in size and number implicates its pathogenesis. Am J Gastroenterol 103:2153–2155PubMedCrossRef
70.
Paradis V, Benzekri A, Dargère D, et al. (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329PubMedCrossRef
71.
Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef
72.
Pupulim LF, Vullierme MP, Paradis V, et al. (2013) Congenital portosystemic shunts associated with liver tumours. Clin Radiol 68:e362–e369PubMedCrossRef
73.
Brisse H, Servois V, Bouche B, et al. (2000) Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol 30:386–393PubMedCrossRef
74.
Donadon M, Di Tommaso L, Roncalli M, Torzilli G (2013) Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy. World J Hepatol 5:340–344PubMedPubMedCentralCrossRef
75.
Kim MJ, Han SY, Baek YH, Lee SW, Kwon HJ (2014) A case of focal nodular hyperplasia with growth progression during pregnancy. Clin Mol Hepatol 20:392–397PubMedPubMedCentralCrossRef
76.
Rifai K, Mix H, Krusche S, et al. (2013) No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy. Scand J Gastroenterol 48:88–92PubMedCrossRef
77.
Mathieu D, Kobeiter H, Maison P, et al. (2000) Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 118:560–564PubMedCrossRef
78.
Chandrasegaram MD, Shah A, Chen JW, et al. (2015) Oestrogen hormone receptors in focal nodular hyperplasia. HPB (Oxford) 17:502–507CrossRef
79.
Crombe A, Alberti N, Balageas P, Frulio N (2015) From a typical focal nodular hyperplasia to a fibrotic band with capsular retraction: a case report. Diagn Interv Imaging 96:391–392PubMedCrossRef
80.
81.
Awaya H, Ito K, Honjo K, et al. (1998) Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 22:180–187PubMedCrossRef
82.
Kakar S, Kamath PS, Burgart LJ (2004) Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment? Arch Pathol Lab Med 128:901–904PubMed
83.
Furlan A, Minervini MI, Borhani AA, et al. (2016) Hepatic sinusoidal dilatation: a review of causes with imaging-pathologic correlation. Semin Ultrasound CT MR 37:525–532PubMedCrossRef
84.
Lapeyre M, Mathieu D, Tailboux L, Rahmouni A, Kobeiter H (2002) Dilatation of the intrahepatic bile ducts associated with benign liver lesions: an unusual finding. Eur Radiol 12:71–73PubMedCrossRef
85.
Rangheard AS, Vilgrain V, Audet P, et al. (2002) Focal nodular hyperplasia inducing hepatic vein obstruction. AJR 179:759–762PubMedCrossRef
86.
Giuliante F, Ardito F, Ranucci G, Giovannini I, Nuzzo G (2011) Giant focal nodular hyperplasia determining Budd-Chiari syndrome: an operative challenge requiring 210 min of liver ischemia. Updates Surg 63:307–311PubMedCrossRef
87.
Van Aalten SM, Thomeer MG, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef
88.
Nault JC, Couchy G, Balabaud C, et al. (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152(880–894):e6
89.
Zucman-Rossi J, Jeannot E, Nhieu JT, et al. (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524PubMedCrossRef
90.
Bioulac-Sage P, Rebouissou S, Thomas C, et al. (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748PubMedCrossRef
91.
Bioulac-Sage P, Laumonier H, Couchy G, et al. (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489PubMedCrossRef
92.
Ronot M, Bahrami S, Calderaro J, et al. (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef
93.
Laumonier H, Bioulac-Sage P, Laurent C, et al. (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef
94.
Dokmak S, Paradis V, Vilgrain V, et al. (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705PubMedCrossRef
95.
Bunchorntavakul C, Bahirwani R, Drazek D, et al. (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 34:664–674PubMedCrossRef
96.
Shafizadeh N, Genrich G, Ferrell L, Kakar S (2014) Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Hum Pathol 45:976–983PubMedCrossRef
97.
Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12:509–522CrossRef
98.
Chun YS, Parker RJ, Inampudi S, et al. (2016) Imaging surveillance of hypervascular liver lesions in non-cirrhotic patients. J Gastrointest Surg 20:564–567PubMedCrossRef
99.
Laurent A, Dokmak S, Nault JC, et al. (2016) European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. HPB (Oxford) 18:748–755CrossRef
100.
Klompenhouwer AJ, Sprengers D, Willemssen FE, et al. (2016) Evidence of good prognosis of hepatocellular adenoma in post-menopausal women. J Hepatol 65:1163–1170PubMedCrossRef
101.
Dharmana H, Saravana-Bawan S, Girgis S, Low G (2017) Hepatocellular adenoma: imaging review of the various molecular subtypes. Clin Radiol 72:276–285PubMedCrossRef
102.
Nakao A, Sakagami K, Nakata Y, et al. (2000) Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 35:557–562PubMedCrossRef
103.
Socas L, Zumbado M, Perez-Luzardo O, et al. (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39:e27PubMedPubMedCentralCrossRef
104.
Karkar AM, Tang LH, Kashikar ND, et al. (2013) Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB 15:235–243PubMedPubMedCentralCrossRef
105.
van Aalten SM, de Man RA, IJzermans JN, Terkivatan T (2012) Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 99:911–916PubMedCrossRef
106.
Bieze M, Phoa SS, Verheij J, van Lienden KP, van Gulik TM (2014) Risk factors for bleeding in hepatocellular adenoma. Br J Surg 101:847–855PubMedCrossRef
107.
Deneve JL, Pawlik TM, Cunningham S, et al. (2009) Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16:640–648PubMedCrossRef
108.
Metadata
Title
Uncommon evolutions and complications of common benign liver lesions
Authors
Federica Vernuccio
Maxime Ronot
Marco Dioguardi Burgio
Jérôme Lebigot
Wassim Allaham
Christophe Aubé
Giuseppe Brancatelli
Valérie Vilgrain
Publication date
01-08-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1427-6

Other articles of this Issue 8/2018

Abdominal Radiology 8/2018 Go to the issue

Invited article

Venous invasion by hepatic tumors: imaging appearance and implications for management

Invited article

Hepatic sinusoidal dilatation

Invited Article

Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future

OriginalPaper

Usefulness of metabolic activity of adipose tissue in FDG PET/CT of colorectal cancer

OriginalPaper

The radiological myometrial appearance after cesarean section: is it associated with postpartum complications and subsequent delivery outcome?

Classics in Abdominal Imaging

‘Stone street’ ureter
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits